(S)-TERT-BUTYL 3-METHOXYPYRROLIDINE-1-CARBOXYLATE, 95.0%, 5g

2-(4-Methylnaphthalen-1-yl)acetic acid, 98%, 500mg

2-(3,5-Dinitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98+%, 250mg

(3-Methyl-2-oxo-2,3-dihydro-benzoimidazol-1-yl)-acetic acid, 95.0%, 2g

Colonna capillare per GC ROTI®Cap-5, 50 m, 0.32 mm, 3.00 µm, 1 Pezzo(i)

3-(4-Fluorophenyl)propanal, 95.0%, 1g

2-(Trifluoromethyl)phenothiazine>98.0%(GC)25g

2-(4-Nitrophenoxy)acetonitrile, 95+%, 25g

7-Chloropyrazolo[1,5-a]pyrimidine, 95.0%, 10g

9-[(2S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one, 98.0%, 25g

Di-n-Butylammonium tetrafluoroborate, 100g

Phenethyl cinnamate, 99.0%, 100g

N-[(1-Chloro-4-hydroxy-3-isoquinolinyl)carbonyl]glycine, 99%, 100mg